| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -31,0 k € | +21.2% | -39,3 k € | -577.9% | -5,8 k € | -136.7% | 15,8 k € | -89.9% | 156,2 k € | -28.4% | 218,0 k € | +6.1% | 205,4 k € | +25.4% | 163,8 k € | -41.1% | 277,9 k € | +34.9% | 205,9 k € | +4.8% | 196,6 k € | +18.2% | 166,3 k € | -32.3% | 245,6 k € | +4.3% | 235,6 k € | -59.8% | 585,4 k € | +6.5% | 549,5 k € | +28.4% | 428,1 k € | +20.6% | 354,8 k € | +10.4% | 321,5 k € | |
| EBITDA | -37,4 k € | +17.8% | -45,5 k € | +14.3% | -53,2 k € | +9.4% | -58,7 k € | -169.5% | 84,4 k € | -41.7% | 144,8 k € | -4.6% | 151,7 k € | +23.3% | 123,1 k € | -48.8% | 240,1 k € | +45.6% | 164,9 k € | +4.7% | 157,5 k € | +24.7% | 126,3 k € | -32.7% | 187,7 k € | +6.5% | 176,2 k € | +441.7% | 32,5 k € | -73.7% | 123,5 k € | +15.1% | 107,3 k € | +51.8% | 70,7 k € | -49.4% | 139,7 k € | |
| Operating profit | -103,6 k € | +12.1% | -117,8 k € | +5.6% | -124,8 k € | +12.2% | -142,1 k € | -10279.6% | -1,4 k € | -103.5% | 39,7 k € | -46.0% | 73,4 k € | +91.7% | 38,3 k € | -74.5% | 150,1 k € | +68.3% | 89,2 k € | +6.4% | 83,9 k € | +63.9% | 51,2 k € | -53.1% | 109,2 k € | +16.6% | 93,6 k € | +249.6% | -62,6 k € | -189.7% | 69,8 k € | +57.8% | 44,2 k € | +129.7% | 19,2 k € | -77.7% | 86,1 k € | |
| Profit/loss | -109,3 k € | +15.6% | -129,5 k € | +5.1% | -136,4 k € | +11.3% | -153,7 k € | -3741.4% | 4,2 k € | -67.7% | 13,1 k € | -58.7% | 31,7 k € | +66.7% | 19,0 k € | -79.4% | 92,3 k € | +116.9% | 42,6 k € | -5.9% | 45,2 k € | +115.4% | 21,0 k € | -64.5% | 59,2 k € | +5.1% | 56,3 k € | +163.7% | -88,3 k € | -371.0% | 32,6 k € | +93.7% | 16,8 k € | +60.1% | 10,5 k € | -80.8% | 54,9 k € | |
| Equity | 3,3 k € | -97.1% | 112,6 k € | -53.5% | 242,0 k € | -36.0% | 378,4 k € | -28.9% | 532,1 k € | +0.8% | 527,9 k € | +2.5% | 514,8 k € | +6.6% | 483,2 k € | +4.1% | 464,2 k € | +24.8% | 371,9 k € | +12.9% | 329,3 k € | +16.9% | 281,7 k € | +8.1% | 260,7 k € | +29.4% | 201,6 k € | +38.7% | 145,3 k € | -37.8% | 233,6 k € | +16.2% | 201,0 k € | +9.1% | 184,2 k € | +6.1% | 173,7 k € | |
| Total assets | 283,4 k € | -27.6% | 391,5 k € | -31.5% | 571,3 k € | -17.5% | 692,4 k € | -22.1% | 889,2 k € | -7.0% | 955,8 k € | +10.3% | 866,4 k € | -2.0% | 883,9 k € | -4.7% | 927,1 k € | +7.8% | 860,1 k € | -0.4% | 863,6 k € | +0.1% | 862,6 k € | -0.9% | 870,5 k € | -2.9% | 896,4 k € | -22.7% | 1,2 M € | +71.2% | 676,9 k € | +8.8% | 622,2 k € | +3.0% | 604,0 k € | +58.9% | 380,1 k € | |
| Cash | 3,6 k € | -84.5% | 23,3 k € | +31.7% | 17,7 k € | -21.7% | 22,5 k € | -75.2% | 90,9 k € | +20.3% | 75,6 k € | -20.7% | 95,3 k € | +31.7% | 72,4 k € | -30.6% | 104,2 k € | -24.9% | 138,8 k € | +286.6% | 35,9 k € | -37.6% | 57,5 k € | +1.7% | 56,6 k € | -14.3% | 66,0 k € | -24.6% | 87,5 k € | -4.5% | 91,6 k € | +534.4% | 14,4 k € | -30.9% | 20,9 k € | +81.4% | 11,5 k € | |
| Debts | 280,1 k € | +0.4% | 278,9 k € | -15.3% | 329,3 k € | +4.9% | 314,0 k € | -12.0% | 357,0 k € | -16.6% | 427,9 k € | +21.7% | 351,5 k € | -12.3% | 400,7 k € | -13.4% | 462,9 k € | -5.2% | 488,3 k € | -8.6% | 534,3 k € | -8.0% | 580,8 k € | -4.7% | 609,8 k € | -1.7% | 620,6 k € | -38.8% | 1,0 M € | +128.7% | 443,3 k € | +5.3% | 421,2 k € | +0.3% | 419,8 k € | +103.4% | 206,4 k € | |
| Staff | — | — | — | — | — | — | — | — | 0,2 | 0,2 | 0,2 | 0,2 | 0,2 | 1,5 | 7,9 | 6,1 | 4,8 | 4,2 | 3 | |||||||||||||||||||
Source: Belgian Official Gazette
Private company with limited liability · Zemst · incorporated on 29/07/1999
Private company with limited liability loss-making in the latest fiscal year. Cash position declining (-84.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDISCH PHARMACEUTISCHE INFORMATIE is a Private company with limited liability incorporated in 1999. Its main activity is: Management consultancy activities. Its registered office is in Zemst.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.